Literature DB >> 8800925

Machado-Joseph disease: correlation between the clinical features, the CAG repeat length and homozygosity for the mutation.

I Lerer1, D Merims, D Abeliovich, J Zlotogora, N Gadoth.   

Abstract

Machado-Joseph disease (MJD) is an autosomal dominant neurodegenerative disorder associated with the expansion of a CAG trinucleotide repeat in the MJD1 gene located on 14q32.1. We confirmed that the CAG expansion caused MJD in a Yemenite Jewish family and demonstrated that most of the clinical variation among members of this family was due to the genotype of the affected individuals. Six patients who presented with an early onset (25 years) and severe disorder were found to be homozygous for the CAG expansion. Among 5 heterozygotes for the CAG expansion older than 40 years, one had neurological symptoms from the age of 45, while the others were asymptomatic. In one of the heterozygotes, no neurological symptoms were present when last examined at the age of 66. Homozygosity for the MJD1 mutation was the main cause of variability in this large family, however, other factors clearly played a role in the expression of the gene. We could demonstrate that homozygote sibs with similar expansion in both alleles had significant differences in disease severity. Gender did not affect the clinical expression in this family.

Entities:  

Mesh:

Year:  1996        PMID: 8800925     DOI: 10.1159/000472162

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  13 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

Review 2.  Machado-Joseph Disease: from first descriptions to new perspectives.

Authors:  Conceição Bettencourt; Manuela Lima
Journal:  Orphanet J Rare Dis       Date:  2011-06-02       Impact factor: 4.123

Review 3.  Machado-Joseph disease/spinocerebellar ataxia type 3.

Authors:  Henry Paulson
Journal:  Handb Clin Neurol       Date:  2012

4.  Chinese homozygous Machado-Joseph disease (MJD)/SCA3: a case report.

Authors:  Sheng Zeng; Junsheng Zeng; Miao He; Xianfeng Zeng; Yao Zhou; Zhen Liu; Hong Jiang; Beisha Tang; Junling Wang
Journal:  J Hum Genet       Date:  2015-01-08       Impact factor: 3.172

5.  Sequence analysis of 5' regulatory regions of the Machado-Joseph disease gene (ATXN3).

Authors:  Conceição Bettencourt; Mafalda Raposo; Nadiya Kazachkova; Cristina Santos; Teresa Kay; João Vasconcelos; Patrícia Maciel; Karina C Donis; Maria Luiza Saraiva-Pereira; Laura B Jardim; Jorge Sequeiros; Jácome Bruges-Armas; Manuela Lima
Journal:  Cerebellum       Date:  2012-12       Impact factor: 3.847

6.  A molecular investigation of true dominance in Huntington's disease.

Authors:  Y Narain; A Wyttenbach; J Rankin; R A Furlong; D C Rubinsztein
Journal:  J Med Genet       Date:  1999-10       Impact factor: 6.318

Review 7.  Huntington's Disease: Relationship Between Phenotype and Genotype.

Authors:  Yi-Min Sun; Yan-Bin Zhang; Zhi-Ying Wu
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

8.  Vestibulo-ocular arreflexia in families with spinocerebellar ataxia type 3 (Machado-Joseph disease).

Authors:  C R Gordon; V Joffe; G Vainstein; N Gadoth
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

9.  Spinocerebellar ataxia type 3 in Israel: phenotype and genotype of a Jew Yemenite subpopulation.

Authors:  Roy Zaltzman; Reuven Sharony; Colin Klein; Carlos R Gordon
Journal:  J Neurol       Date:  2016-08-08       Impact factor: 4.849

Review 10.  Spinocerebellar ataxia type 17 is caused by mutations in the TATA-box binding protein.

Authors:  Christine Zühlke; Katrin Bürk
Journal:  Cerebellum       Date:  2007-01-19       Impact factor: 3.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.